Abpro has a highly talented team of immunoassay scientists with extensive assay development experience. Our team has delivered high quality, functional monoclonal antibodies and corresponding assays to traditionally difficult targets (e.g., GPCRs, high homology proteins, idiotypes). Our expertise includes, but is not limited to sandwich ELISAs for diagnostic kit development, competition, neutralizing, and blocking assays for drug screening and development.
In addition to assay development, we also have high throughput screening capabilities. Our platform leverages state-of-the-art automation to process and screen a huge volume of samples accurately and efficiently. Our screening capabilities include:
- Affinity Ranking (ForteBio Octet™)
- Western Blots
- Flow Cytometry
- Dot Blot